- About MHRP
- International Network
- Prevention, Care & Treatment
- News & Publications
An Army-sponsored phase III clinical trial (RV144) involving more than 16,000 adult volunteers in Thailand showed that an investigational HIV vaccine regimen was safe and modestly effective in preventing HIV infection.
This HIV Vaccine Awareness Day, we reflect upon how much we've learned in the quest for an effective vaccine. While we don't have a vaccine yet, we know a vaccine is possible and will be a critical tool to help end the epidemic.
In a ceremony held May 1, Col. Nelson Michael received the Hero of Military Medicine Award for the U.S. Army for his excellence as an HIV researcher and leader in global health.
A research team led by the Duke and MHRP won the “Best Academic Research Team” award at the 6th Vaccine Industry Excellence Awards ceremony at the World Vaccine Congress.
MHRP Profiles: Ebola Vaccine Trial Participant
Jackson Otim Oyugi is a soft spoken and multi-talented gentleman. He is also is a first cousin to Dr. Mathew Lukwiya, the first medical officer to die in the line of duty during Uganda’s first Ebola outbreak in Gulu district in 2000. Jackson is participating in the first phase I Ebola/Marburg vaccine clinical trial on the African continent.
Video: The African Cohort Study (AFRICOS)
An important new study will recruit 3,600 individuals in Africa to help researchers better understand what leads to the best clinical outcomes. Throughout this 15-year study, MHRP researchers will look at current national treatment regimens and long-term outcomes such as time to progression to AIDS and mortality, as well as non-infectious co-morbidities such as TB and malaria. Watch the video to learn more!